ProShare Advisors
CMPX icon

ProShare Advisors’s Compass Therapeutics CMPX Stock Holding History

ProShare Advisors’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$98.9K Sell
18,703
-5,269
-22% -$30.4K ﹤0.01% 1706
2025
Q4 		$129K Buy
23,972
+6,968
+41% +$32.2K ﹤0.01% 1825
2025
Q3 		$59.5K Sell
17,004
-1,791
-10% -$5.66K ﹤0.01% 1918
2025
Q2 		$48.9K Sell
18,795
-3,284
-15% -$6.77K ﹤0.01% 1995
2025
Q1 		$42K Sell
22,079
-6,643
-23% -$17.7K ﹤0.01% 1970
2024
Q4 		$41.6K Buy
28,722
+9,451
+49% +$15.7K ﹤0.01% 2203
2024
Q3 		$35.5K Buy
19,271
+7,048
+58% +$8.79K ﹤0.01% 2015
2024
Q2 		$12.2K Sell
12,223
-4,173
-25% -$6.09K ﹤0.01% 1830
2024
Q1 		$32.5K Buy
16,396
+1,292
+9% +$2.23K ﹤0.01% 1951
2023
Q4 		$23.6K Buy
15,104
+3,248
+27% +$5.62K ﹤0.01% 1913
2023
Q3 		$23.4K Sell
11,856
-12
-0.1% -$30 ﹤0.01% 1777
2023
Q2 		$37.7K Buy
+11,868
New +$37.3K ﹤0.01% 1797

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM